141 related articles for article (PubMed ID: 30861604)
1. Procyanidin B2 from lotus seedpod regulate NO/ADMA/DDAH pathway to treat insomnia in rats.
Xiao HB; Wang YS; Liang L; Lu X; Sun ZL
Fundam Clin Pharmacol; 2019 Oct; 33(5):549-557. PubMed ID: 30861604
[TBL] [Abstract][Full Text] [Related]
2. SZSJ protects against insomnia by a decrease in ADMA level and an improvement in DDAH production in sleep-deprived rats.
Xiao HB; Wang YS; Luo ZF; Lu XY
Life Sci; 2018 Sep; 209():97-102. PubMed ID: 30048696
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
4. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
[TBL] [Abstract][Full Text] [Related]
5. A significant inhibitory effect on advanced glycation end product formation by catechin as the major metabolite of lotus seedpod oligomeric procyanidins.
Wu Q; Li S; Li X; Fu X; Sui Y; Guo T; Xie B; Sun Z
Nutrients; 2014 Aug; 6(8):3230-44. PubMed ID: 25123249
[TBL] [Abstract][Full Text] [Related]
6. The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine.
Milewski K; Hilgier W; Albrecht J; Zielińska M
Neurochem Int; 2015 Sep; 88():26-31. PubMed ID: 25523831
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Wang S; Hu CP; Jiang DJ; Peng J; Zhou Z; Yuan Q; Nie SD; Jiang JL; Li YJ; Huang KL
J Neurosci Res; 2009 Jun; 87(8):1938-46. PubMed ID: 19156866
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of lotus seedpod procyanidins on extremely low frequency electromagnetic field-induced neurotoxicity in primary cultured hippocampal neurons.
Yin C; Luo X; Duan Y; Duan W; Zhang H; He Y; Sun G; Sun X
Biomed Pharmacother; 2016 Aug; 82():628-39. PubMed ID: 27470406
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Selley ML
J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.
Greco R; Ferrigno A; Demartini C; Zanaboni A; Mangione AS; Blandini F; Nappi G; Vairetti M; Tassorelli C
J Headache Pain; 2015; 16():560. PubMed ID: 26272684
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
Wu Y; Zhang JJ; Li TB; Liu WQ; Li LS; Luo XJ; Jiang JL; Ma QL; Yang ZC; Peng J
J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):536-548. PubMed ID: 26911182
[TBL] [Abstract][Full Text] [Related]
16. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
17. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
[TBL] [Abstract][Full Text] [Related]
19. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway.
Chen D; Zhang KQ; Li B; Sun DQ; Zhang H; Fu Q
Asian J Androl; 2017; 19(3):291-297. PubMed ID: 27080477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
